 Hood SC, Moher D, Barber GG. Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled
trials. CMAJ 1996;155:1053-9.
91. Porter JM, Cutler BS, Lee BY, Reich T, Reichle FA, et al. Pentoxifylline
efÔ¨Åcacy in the treatment of intermittent claudication: multicenter
controlled double-blind trial with objective assessment of chronic
occlusive arterial disease patients. Am Heart J 1982;104:66-72.

36S Conte and Pomposelli et al

92. Robless P, Mikhailidis DP, Stansby GP. Cilostazol for peripheral
arterial disease. Cochrane Database Syst Rev 2008;(1):CD003748.
93. De Backer T, Vander Stichele R, Lehert P, Van Bortel L. Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data. BMJ 2009;338:b603.
94. de Backer TL, Vander Stichele R, Lehert P, Van Bortel L. Naftidrofuryl for intermittent claudication. Cochrane Database Syst Rev
2012;12(1):CD001368.
95. Salhiyyah K, Senanayake E, Abdel-Hadi M, Booth A, Michaels JA.
Pentoxifylline for intermittent claudication. Cochrane Database Syst
Rev 2012;1:CD005262.
96. Dawson DL, Cutler BS, Hiatt WR, Hobson RW 2nd,
Martin JD, Bortey EB, et al. A comparison of cilostazol and
pentoxifylline for treating intermittent claudication. Am J Med
2000;109:523-30.
97. Effects of ramipril on cardiovascular and microvascular outcomes in
people with diabetes mellitus: results of the HOPE study and
MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation
Study Investigators